Abstract: An apparatus, system, and method for fast all-optical switching is presented. In one embodiment, the apparatus includes a first light transmitting medium. The apparatus may also include a second light transmitting medium coupled to the first light transmitting medium and disposed to form an interface region between the first light transmitting medium and the second light transmitting medium. Additionally, the apparatus may include a plurality of Lambda atoms disposed in the interface region, the Lambda atoms adapted to cause Electromagnetically-Induced Transparency (EIT) in the interface region in response to an incident photon.
Type:
Grant
Filed:
May 12, 2010
Date of Patent:
September 11, 2012
Assignee:
UTI Limited Partnership
Inventors:
Sergey Moiseev, Ali Kamli, Barry Sanders
Abstract: A method and apparatus for reducing power consumption in a wireless communication system is described. Sending of unicast packets to an access terminal is ceased. It is determined if a ReverseTrafficChannelMAC.UATIReceived indication is received, wherein MAC is medium access control and UATI is unicast access terminal identifier. The access network transitions to a BindUATI state.
Type:
Grant
Filed:
October 27, 2006
Date of Patent:
September 11, 2012
Assignee:
Qualcomm Incorporated
Inventors:
Rajat Prakash, Fatih Ulupinar, Aamod Khandekar
Abstract: The invention provides a molecular affinity clamp. The architecture of the affinity clamp is modular with two biorecognition modules, each capable of binding a target motif. The first biorecognition module has a recognition domain that possesses inherent or natural specificity for the target motif. The second biorecognition module also has a recognition domain that binds the motif. The two biorecognition modules are tethered together either directly, e.g., via a peptide bond between the two modules, or indirectly, e.g., via a linker moiety or linker. The invention further provides a novel affinity ligand which is specifically bound by the molecular affinity clamps of the invention.
Abstract: A process for the in-flight surface treatment of powders using a Dielectric Barrier Discharge Torch operating at atmospheric pressures or soft vacuum conditions is described herein. The process comprising feeding a powder material into the Dielectric Barrier Discharge Torch yielding powder particles exhibiting a reduced powder agglomeration feature; in-flight modifying the surface properties of the particles; and collecting coated powder particles. An apparatus for surface treating micro- and nanoparticles comprising a Dielectric Barrier Discharge Torch operating at atmospheric pressure or soft vacuum conditions is also described herein.
Type:
Grant
Filed:
July 31, 2007
Date of Patent:
September 11, 2012
Assignee:
Tekna Plasma Systems Inc.
Inventors:
Maher I. Boulos, Ulrich Kogelschatz, Christine Nessim
Abstract: The disclosures made herein relate to an infusion device specifically adapted for syringe injections. In one embodiment of the disclosures made herein, an infusion device comprises a body including an accessible surface having a single inlet port therein, an engagement surface having a single outlet port therein, a medication delivery channel extending between the single inlet port and the single outlet port, and an identification feature on the accessible surface of the body adjacent to the single inlet port. The single inlet port of the medication delivery channel is tapered thereby forming a funnel-shaped entry into the medication delivery channel. A cannula is coupled to the body at the single outlet port and is adapted for receiving medication from the single outlet port and transmitting the medication therethrough.
Abstract: The present invention relates to a method and system for textual exploration and discovery. More specifically, the method and system provide a text-driven and grammar based tool for textual exploration and textual navigation. The facilities for textual exploration and textual navigation are based on a system of index entries that are connected to the underlying text segments from which the index entries are derived. Text units with particular grammatical, semantic, and/or pragmatic features constitute bundles of sentences or text zones.
Abstract: A composition comprising a glyceryl salicylate compound and/or a glycol salicylate compound. The compositions can be used to reduce the amount of moisture evaporated from skin, protect the skin from UV light, and treat aged or damaged skin.
Abstract: A food product formulation which includes dried hen egg albumen (white), wherein the level of said albumen in said formulation is based on the water absorption or water binding (gelling) capacity of said albumen.
Abstract: The present invention is directed to compositions and methods related to soluble G-protein coupled receptors (sGPCR). In certain aspects the invention includes compositions and methods related to a soluble corticotropin releasing factor receptor related protein, sCRFR2, as well as its effects on CRFR signaling and interaction between CRF family ligand and CRFR receptors, including but not limited to CRFR2, CRFR1 and functional or signaling capable variants thereof.
Abstract: This invention provides novel compounds comprising the following anti-inflammatory pharmacore: wherein X, R1 and R2 are defined herein. Also provided are pharmaceutical compositions, kits and articles of manufacture comprising such compounds, methods and intermediates useful for making the compounds, and methods of using the compounds and compositions.
Type:
Grant
Filed:
April 20, 2009
Date of Patent:
September 4, 2012
Assignee:
Reata Pharmaceuticals, Inc.
Inventors:
Eric Anderson, Gary L. Bolton, Deborah A. Ferguson, Xin Jiang, Robert M. Kral, Jr., Patrick M. O'Brien, Melean Visnick
Abstract: The present invention relates to an air supply system for a vehicle, which includes a curved diffuser passageway and a volute formed on upper portion of the diffuser passageway to sufficiently secure a length of the diffuser passageway, thereby enhancing a pressure conversion efficiency and reducing a size of the entire system, and which further includes a guide for guiding an air flow toward an input of an impeller, thereby minimizing a loss occurring when air passing through a motor housing flows to the inlet of the impeller, and reducing a weight of an outlet duct.
Type:
Grant
Filed:
January 10, 2008
Date of Patent:
September 4, 2012
Assignee:
Halla Climate Control Corporation
Inventors:
Kyungseok Cho, Woojune Kim, Changhoon Oh
Abstract: In one exemplary embodiment, a method comprises transmitting an optical signal via the optical line, measuring a relative change in spectral intensity of the optical signal near a clock frequency (or half of that frequency) while varying a polarization of the optical signal between a first state of polarization and a second state of polarization, and using the relative change in spectral intensity of the optical signal to determine and correct the DGD of the optical line. Another method comprises splitting an optical signal traveling through the optical line into a first and second portions having a first and second principal states of polarization of the optical line, converting the first and second portions into a first and second electrical signals, delaying the second electrical signal to create a delayed electrical signal that compensates for a DGD of the optical line, and combining the delayed electrical signal with the first electrical signal to produce a fixed output electrical signal.
Abstract: The present invention concerns methods and compositions for diagnosing and/or treating vascular diseases including cancer, cardiac diseases, vascular diseases of the eye, and inflammatory diseases. The methods involve measuring the levels of one or multiple miRNAs in patient samples and using the test results to diagnose and/or predict an optimal treatment regimen for the patient. Compositions described in the invention include nucleic acids that function as miRNAs or miRNA inhibitors that can be introduced to a patient to reduce or increase vascularization as needed.
Type:
Grant
Filed:
May 8, 2009
Date of Patent:
September 4, 2012
Assignees:
The Johns Hopkins University, MIRNA Therapeutics, Inc.
Inventors:
Jikui Shen, Kevin Kelnar, Jeffrey Shelton, David Brown, Peter Campochiaro
Abstract: The present invention relates generally to the field of inflammatory diseases of the peripheral nervous system. More particularly, it concerns methods for treating inflammatory diseases of the peripheral nervous system by modulating sphingosine-1-phosphate receptor activity. In one embodiment, the present invention provides a method of treating a subject with chronic inflammatory demyelinating polyneuropathy (CIDP) or other autoimmune neuropathies comprising administering to the subject an effective amount of FTY720.
Abstract: The present invention relates to a method and device for determining a level of ventilatory assist to a ventilator-dependent patient, in which a critical threshold of a respiration-related feature is calculated. Fatigue of a respiratory muscle of the ventilator-dependent patient develops when the critical threshold is reached by the respiration-related feature. The level of ventilatory assist to the ventilator-dependent patient is controlled in relation to the critical threshold of the respiration-related feature so as to prevent fatigue of the patient's respiratory muscle.
Type:
Grant
Filed:
February 18, 2005
Date of Patent:
September 4, 2012
Assignee:
Maquet Critical Care AB
Inventors:
Christer Sinderby, Jennifer Beck, Jadranka Spahija, Lars Lindstrom
Abstract: Caps and container systems suited to dispensing products like cosmetics. Some of the caps include two portions that can be coupled together and that include a dispensing system that has at least two open positions and at least one closed position.
Abstract: Novel methods and compositions for treating aged and environmentally damaged skin are disclosed which provide improvements in the skin's visual appearance, function and clinical/biophysical properties by activating at least one proteolytic enzyme in the skin's stratum corneum. The disclosed treatment methods involve topical application of a novel cosmetic composition containing a combination of a cationic surfactant such as N,N,-dimethyldodecyl amine oxide (DMDAO), an anionic surfactant such as sodium dodecyl sulfate (SDS), or monoalkyl phosphate (MAP) and a chelating agent such as ethylene diamine tetraacetate (EDTA) to stimulate a chronic increase in the replacement rate of the skin's stratum corneum by means of corneum protease activation. This chronic, low level stimulation is effective to induce repair and replacement of the stratum corneum, epidermis, and dermis of the skin and improvements in the appearance, function, and anti-aging properties of the skin.
Abstract: An integrated system and method of integrating fluid dispensing technologies (e.g., direct-write (DW)) with rapid prototyping (RP) technologies (e.g., stereolithography (SL)) without part registration comprising: an SL apparatus and a fluid dispensing apparatus further comprising a translation mechanism adapted to translate the fluid dispensing apparatus along the Z-, Y- and Z-axes. The fluid dispensing apparatus comprises: a pressurized fluid container; a valve mechanism adapted to control the flow of fluid from the pressurized fluid container; and a dispensing nozzle adapted to deposit the fluid in a desired location. To aid in calibration, the integrated system includes a laser sensor and a mechanical switch. The method further comprises building a second part layer on top of the fluid deposits and optionally accommodating multi-layered circuitry by incorporating a connector trace.
Type:
Grant
Filed:
December 23, 2009
Date of Patent:
August 28, 2012
Assignees:
Board of Regents, The University of Texas System, Sandia Corporation, Operator of Sandia National Laboratories
Inventors:
Francisco Medina, Ryan Wicker, Jeremy A. Palmer, Don W. Davis, Bart D. Chavez, Phillip L. Gallegos